PathAI logo

The Boston Globe Names Andy Beck to Tech Power Players 50

The Award Honors the Most Influential Leaders In New England Technology Spanning Health Tech, Climate Tech, Robotics and AI and More

BOSTON, MA – May 9, 2024 – PathAI co-founder and CEO Andy Beck, MD, PhD, ​has been named to the Boston Globe’s third annual Tech Power Players 50, a list of the most influential – and interesting – people in the New England technology scene, as ranked by The Boston Globe’s business journalists and an external advisory committee.

The Tech Power Players 50 recognizes leaders across the technology sector including software, cybersecurity, AI and robotics, climate tech, health tech, crypto, and beyond. The list examines their career impact on technology and business, considering their tech-specific contributions and innovations that have kept the sector vibrant in a challenging economic climate.

The advisory committee and the Globe’s newsroom also considered each leader’s involvement in the Massachusetts tech community and the degree to which they engage with local efforts to promote diversity, equity, and inclusion.

“Boston is a leader in tech and innovation, and we’re seeing a lot of opportunity even in a challenging economy,” said Greg Huang, the Globe’s Business and Tech editor. “In our third year, we wanted the power players list to both stand alone and reflect broader trends in the industry, including the surging interest in fields like AI and climate tech.”

“I’m honored to be included on this list along with such dedicated and creative tech leaders here in New England,” said Dr. Beck. “The Boston area is an ideal place to build a tech company – with world class institutions, great talent and a rich community of individuals passionate about making improvements in healthcare. As an organization, we’re proud to be part of Boston’s thriving tech community, and we look forward to continued dialogue and innovation with our colleagues and neighbors.”

About PathAI
PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and laboratory use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of pathology samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases.

PathAI is headquartered in Boston, MA. For more information, please visit

Get In Touch

For media inquiries, please contact:

Maggie Naples
SVM Public Relations and Marketing Communications
[email protected]
+1 401-490-9700
Path AI seating area overlooking Fenway Park in Boston